CCL15 was elevated in the bronchoalveolar lavage fluid (BALF) obtained from patients with stage III sarcoidosis [26] and in peripheral blood from patients with severe persistent asthma, while anti-IgE antibody therapy reduced the CCL15 level of severe asthma patients [7]. This evidence concerns the gene CCL15 and asthma.